EFAI NeuroSuite CT ICH Assessment System

by Ever Fortune.AI Co.  · Based in Taiwan →Beyond Medicine. Anytime. Anywhere.
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

The EFAI NeuroSuite CT ICH Assessment System (EFAI ICHCT) is a radiological computer-assisted triage and notification software system developed by Ever Fortune.AI Co. It leverages advanced deep learning techniques to automatically analyze non-contrast head CT scans. The system is designed to identify features suggestive of acute intracranial hemorrhage (ICH) and then alert the Picture Archiving and Communication System (PACS) or Radiology Information System (RIS) workstation.

This AI tool aims to aid in prioritizing the clinical assessment of adult non-contrast head CT cases with suspected acute ICH, thereby accelerating interpretation time for physicians. It can accurately detect and identify five types of ICH. The system provides a passive notification for worklist prioritization or triage, but it does not mark, highlight, or direct users’ attention to specific locations on the original non-contrast head CT images. It is compatible with major CT scanner brands such as Siemens, Philips, GE, and Canon.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automatically analyzes non-contrast head CTs for acute ICH.
  • Uses deep learning techniques for detection.
  • Alerts PACS/RIS workstations for prioritization.
  • Aids in prioritizing clinical assessment of adult non-contrast head CT cases.
  • Accurately detects and identifies five types of ICH.
  • Compatible with major CT scanner brands (e.g., Siemens, Philips, GE, Canon).
  • Provides passive notification for worklist prioritization or triage.
  • Does not mark, highlight, or direct user attention to specific locations on images.

Use Cases

  • Expedited diagnosis of acute intracranial hemorrhage in emergency departments.
  • Prioritization of radiological medical images for review.
  • Triage of non-contrast head CT scans.
  • Enhancing clinical workflow for radiologists and medical professionals.

What Physicians Need to Know

Stroke Detection Speed
Detects acute intracranial hemorrhage (ICH) on non-contrast CT scans in 34.96 seconds.
Brain CT Analysis
Automatically analyzes non-contrast head CTs using deep learning to detect and identify five types of acute intracranial hemorrhage (ICH). It also includes a separate system for midline shift assessment.
Triage Prioritization Speed
Functions as a radiological computer-assisted triage and notification software system, providing case-level output to PACS/RIS workstations for worklist prioritization. It passively notifies radiologists of cases suggestive of acute ICH, enabling earlier review.
Mobile Notification System
Offers automated mobile text notifications to instantly alert physicians about suspected acute hemorrhage, thereby accelerating interpretation time.
Physician Tip

This tool is specifically designed for the rapid detection and triage of intracranial hemorrhage (ICH) on non-contrast head CTs, which is critical for managing hemorrhagic stroke. Physicians should leverage its fast detection speed and notification system to prioritize urgent cases and streamline workflow. It's important to note that this system focuses on ICH and midline shift, and is not indicated for ischemic stroke assessments like large vessel occlusion (LVO) detection or automated ASPECTS scoring.

The EFAI NeuroSuite CT ICH Assessment System is designed to integrate with existing hospital Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) for worklist prioritization and notifications. It is compatible with major CT manufacturers, including Siemens, Philips, GE, and Canon.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentOn-premise, installed on a specialized server within a local network with an existing hospital-grade IT system.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The EFAI NeuroSuite CT ICH Assessment System (EFAI ICHCT) received U.S. FDA clearance (K231025) on October 4, 2023. It is classified as a Class II Radiological Computer Aided Triage and Notification Software (Product Code QAS).

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate EFAI NeuroSuite CT ICH Assessment System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for EFAI NeuroSuite CT ICH Assessment System.

Loading videos...

View all on YouTube

Frequently Asked Questions

EFAI NeuroSuite is designed to seamlessly integrate with existing CT workflows and PACS systems, often by prioritizing worklists and streamlining communication for urgent cases. While AI aims to optimize workflows and reduce delays, some studies indicate that AI triage systems may not always improve diagnostic performance or report turnaround times for intracranial hemorrhage detection.
EFAI NeuroSuite, as an AI-powered medical device, would require specific regulatory approvals such as FDA clearance in the US and CE Mark in the EU, adhering to regulations like EU MDR and the forthcoming EU AI Act. Data privacy and security are paramount, with compliance to standards like HIPAA for protected health information being crucial for its design and deployment.
The diagnostic performance of AI tools for ICH detection can vary; some systems report high sensitivity and specificity, while others show no significant difference or even slightly lower specificity compared to unassisted radiologists. Known limitations include potential lower detection rates for specific ICH subtypes, susceptibility to false positives from artifacts or other conditions, and challenges in generalizability across diverse patient populations or atypical cases.
EFAI NeuroSuite operates within a landscape of various AI-powered ICH assessment tools, and its performance should be benchmarked against these as well as the established standard of care: manual interpretation by radiologists. While AI can serve as a 'second reader' to complement human evaluation, radiologists often maintain their role as the gold standard in ICH diagnosis. Unique differentiators would typically lie in its specific algorithm design, integration capabilities, and validated performance characteristics in diverse clinical settings.
Pricing models for healthcare AI solutions commonly include subscription-based, pay-per-use, or custom/tiered structures, with costs encompassing software licenses, hardware, and infrastructure. While AI has the potential to increase economic value in radiology, evidence for its cost-effectiveness is often limited, model-based, and highly context-dependent, requiring robust clinical and economic validation.
Physicians retain the ultimate responsibility to exercise independent judgment and adhere to the standard of care, even when using AI systems, as they can be held liable for failing to critically evaluate AI recommendations. Healthcare institutions may also face liability for inadequate training, updates, or support for AI algorithms. Comprehensive training and clear guidelines on the system's capabilities and limitations are essential to mitigate risks and ensure responsible use.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

More from Ever Fortune. AI

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Ever Fortune.AI Co.
Radiology & Imaging AI
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is an FDA-cleared AI software that quantifies bone age from left-hand X-rays for pediatric patients (2-16 years old), assisting radiologists in diagnosis and workflow efficiency.
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM
Ever Fortune.AI
Cardiology AI
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM is an AI-powered radiological computer-assisted triage and notification software that rapidly detects features suggestive of acute aortic dissection or intramural hematoma from CTA images, alerting PACS/RIS workstations for earlier review.
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)
Ever Fortune.AI
Radiology & Imaging AI
AI-powered computer-aided triage and notification software for assessing malpositioned endotracheal tubes on chest X-rays, designed to enhance patient safety and improve clinical outcomes through rapid alerts.
EFAI ChestSuite XR Pleural Effusion Assessment System
Ever Fortune.AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.